A Study Evaluating FEtal MOnitoring During Exercise


About this study

The purpose of this study is to develop an unobtrusive means of acquiring the fetal electrocardiogram (fECG) during exercise to determine heart rate and to characterize fetal status (ST, T wave, and additional analysis) by means of an abdominal recording device. The device will be used to evaluate the safety of the fetus during exercise in order to develop medical guidelines for the higher limits of pregnant women during strenuous exercise.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Healthy, pregnant women 26 – 36 weeks gestation with a singleton pregnancy and accurate dating (last menstrual period confirmed by 1st or 2nd trimester ultrasound).
  • Currently receiving routine prenatal care will be recruited.

Exclusion Criteria:

Any medical/obstetrical contra-indication to exercise during pregnancy per ACOG guidelines, including:

  • Hemodynamically significant heart disease.
  • Restrictive lung disease.
  • Incompetent cervix/cerclage.
  • Increased risk for premature labor .

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Linda Szymanski, M.D., Ph.D.

Open for enrollment

Contact information:

Jennifer Dugan

(507) 538-1125


More information


Publications are currently not available

Mayo Clinic Footer